Margaret M Fitzpatrick's Net Worth
$0
Who is Margaret M Fitzpatrick?
Margaret M Fitzpatrick does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Vistagen Therapeutics, Inc., and AN2 Therapeutics, Inc..
SEC CIK
Margaret M Fitzpatrick's CIK is 0001873879
Past Insider Trading and Trends
2022 was Margaret M Fitzpatrick's most active year for acquiring shares with 3 total transactions. Margaret M Fitzpatrick's most active month to acquire stocks was the month of April. 2022 saw Margaret M Fitzpatrick paying a total of $0.00 for 121,825 shares, this is the most they've acquired in one year.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Vistagen Therapeutics, Inc. (VTGN) Snapshot price: $4.87
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 21
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
AN2 Therapeutics, Inc. (ANTX) Snapshot price: $20.04
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||